|
N = 20
| |
|
Gender n (%)
| |
|
Male
|
12 (60.0)
|
|
Female
|
8 (40.0)
|
|
Age mean (range, SD)
|
76.7 (75–85)
|
|
Year of operation n (%)
| |
|
1996–2002
|
0
|
|
2003–2007
|
6 (30.0)
|
|
2008–2013
|
14 (70.0)
|
|
Diagnosis n (%)
| |
|
CRC (n = 184)
|
5 (25.0)
|
|
PMP (n = 157)
|
6 (30.0)
|
|
Mesothelioma (n = 53)
|
2 (10.0)
|
|
Appendiceal cancer (n = 137)
|
6 (30.0)
|
|
Others (n = 80)
|
1 (5.0)
|
|
HIPEC n (%)
|
9 (45.0)
|
|
EPIC n (%)
|
5 (25.0)
|
|
PCI mean (SD)
|
22.8 (13.0)
|
|
CC n (%)
| |
|
0
|
11 (55.0)
|
|
1
|
5 (25.0)
|
|
2
|
3 (15.0)
|
|
3
|
0 (0)
|
|
Transfusion mean (SD)
|
5.2 (6.2)
|
|
Total hospital stay (days) median (range)
|
20.0 (9–157)
|
|
ICU stay (days) median (range)
|
2.0 (1–101)
|
|
HDU stay (days) median (range)
|
1.0 (0–20)
|
|
Hospital death n (%)
|
1 (5)
|
|
Complication grade n (%)
| |
|
0
|
5 (25.0)
|
|
I
|
1 (5.0)
|
|
II
|
4 (20.0)
|
|
III
|
6 (30.0)
|
|
IV
|
4 (20.0)
|
|
Tumour-related OS median (months) (95 %)
|
35.0 (17.3–52.7)
|
|
5-year OS (%)
|
18.6
|
